Clinical Trial Update: Stem Cell Transplant for High Risk Central Nervous System (CNS) Tumors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on stem cell transplant for high-risk CNS tumors including glioblastoma and astrocytoma; trial completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Astrocytoma
• Glioblastoma
• Pineoblastoma
• Rhabdoid Tumor
• Supratentorial Neoplasms

Snippet

Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago | Conditions: Glioblastoma, Astrocytoma | Phase 2 | Status: COMPLETED